Local Bioequivalence
Local Bioequivalence is a methodological criterion within bioequivalence assessment that specifies the equivalence of drug exposure at a specific anatomical or physiological site, as opposed to systemic circulation, thereby focusing on localized pharmacokinetic or pharmacodynamic outcomes.
12
Publications
392
Citations
67
Authors
29
Institutions
Publications per year
2017–2026
4
Parents
12
Rohit Kumar, Mohamed Azmi Hassali, Fahad Saleem et al. · Journal of Pharmaceutical Policy and Practice · 2015 · 40 citations · Full text
1–5 of 12
67
1
h-index
1
h-index
1
h-index
1
h-index
Alnylam Pharmaceuticals (United States), United States
1 publications · 19 citations
1
h-index
1–5 of 67
29
Center for Drug Evaluation and Research
Silver Spring, United States
2 h-index
9 publications
190 citations
United States Food and Drug Administration
Silver Spring, United States
2 h-index
9 publications
190 citations
Institute for Asthma and Allergy
Wheaton, United States
1 h-index
1 publications
16 citations
Albert Einstein College of Medicine
Bronx, United States
1 h-index
1 publications
22 citations

University of Cologne
Cologne, Germany
1 h-index
6 publications
132 citations
AstraZeneca (France)
Courbevoie, France
1 h-index
1 publications
19 citations

Universiti Sains Malaysia
George Town, Malaysia
1 h-index
4 publications
160 citations

Karolinska Institutet
Stockholm, Sweden
1 h-index
6 publications
84 citations
1–8 of 29
2 publications · 43 citations
2
h-index
AAPSJ · 1 publications · 19 citations
1
h-index
1 publications · 19 citations
1
h-index
1 publications · 16 citations
1
h-index
1 publications · 42 citations
1
h-index
1–5